Incyte Corp. operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Incyte Corp. with three other
companies in this sector in the United States:
sales of $1.67 billion
Albany Molecular Research Incorporated
of which 61%
was API), and
INC Research Holdings Inc
of which 63%
was Clinical Development Services).
During the year ended December of 2016, sales at
Incyte Corp. were $1.11 billion.
increase of 46.7%
versus 2015, when the company's sales were $753.75 million.
This was the fifth consecutive year of sales increases at Incyte Corp.
(and since 2011, sales have increased a total of 1,071%).